{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T22:56:29Z","timestamp":1779058589632,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Foundation","doi-asserted-by":"crossref","award":["4706174"],"award-info":[{"award-number":["4706174"]}],"id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","award":["7360411"],"award-info":[{"award-number":["7360411"]}],"id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Helsinki University Central Hospital Competitive Research Fund","award":["TYH2020208"],"award-info":[{"award-number":["TYH2020208"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Eccrine porocarcinoma (EPC) is a rare malignant adnexal tumour of the skin. Part of EPCs develop from their benign counterpart, poroma (EP), with chronic light exposure and immunosuppression hypothesized to play a role in the malignant transformation. However, the impact of chronic light exposure on the microenvironment of EPCs and EPs has not been investigated yet. Although the clinical relevance of tumour infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) has been established in various tumours, their distribution and significance in EPCs and EPs is still poorly understood. We characterized the distribution of TILs and TLSs using CD3, CD4, CD8, CD20 immunohistochemistry in a cohort of 10 EPCs and 49 EPs. We then classified our samples using solar-elastosis grading, analyzing the influence of ultraviolet (UV) damage on TIL density. A negative correlation between UV damage and TIL density was observed (CD4 r\u2009=\u2009\u22120.286, p\u2009=\u20090.04. CD8 r\u2009=\u2009\u22120.305, p\u2009=\u20090.033). No significant difference in TIL density was found between EPCs and EPs. TLS was scarse with the presence rate 10% in EPCs and 8.3% in EPs. The results suggest that UV has an immunosuppressive effect on the microenvironment of EPCs and EPs.<\/jats:p>","DOI":"10.1038\/s41598-022-09490-5","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:21:23Z","timestamp":1648808483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["UV-induced local immunosuppression in the tumour microenvironment of eccrine porocarcinoma and poroma"],"prefix":"10.1038","volume":"12","author":[{"given":"Maya","family":"Puttonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Isola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onni","family":"Ylinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"B\u00f6hling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virve","family":"Koljonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harri","family":"Sihto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"9490_CR1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1365-2133.2011.10486.x","volume":"165","author":"E Belin","year":"2011","unstructured":"Belin, E. et al. Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure. Br. J. Dermatol. 165, 985\u2013989. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10486.x (2011).","journal-title":"Br. J. Dermatol."},{"key":"9490_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/bjd.18874","volume":"183","author":"S Behbahani","year":"2020","unstructured":"Behbahani, S. et al. Demographics and outcomes of eccrine porocarcinoma: Results from the National Cancer Database. Br. J. Dermatol. 183, 161\u2013163. https:\/\/doi.org\/10.1111\/bjd.18874 (2020).","journal-title":"Br. J. Dermatol."},{"key":"9490_CR3","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/00000478-200106000-00002","volume":"25","author":"A Robson","year":"2001","unstructured":"Robson, A. et al. Eccrine porocarcinoma (malignant eccrine poroma): A clinicopathologic study of 69 cases. Am. J. Surg. Pathol. 25, 710\u2013720. https:\/\/doi.org\/10.1097\/00000478-200106000-00002 (2001).","journal-title":"Am. J. Surg. Pathol."},{"key":"9490_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1590\/S1807-59322010000700014","volume":"65","author":"A Luz Mde","year":"2010","unstructured":"Luz Mde, A., Ogata, D. C., Montenegro, M. F., Biasi, L. J. & Ribeiro, L. C. Eccrine porocarcinoma (malignant eccrine poroma): a series of eight challenging cases. Clinics 65, 739\u2013742. https:\/\/doi.org\/10.1590\/S1807-59322010000700014 (2010).","journal-title":"Clinics"},{"key":"9490_CR5","doi-asserted-by":"publisher","first-page":"adv00363","DOI":"10.2340\/00015555-3718","volume":"101","author":"AS Merilainen","year":"2021","unstructured":"Merilainen, A. S., Pukkala, E., Bohling, T. & Koljonen, V. Malignant eccrine porocarcinoma in Finland during 2007 to 2017. Acta Derm. Venereol. 101, adv00363. https:\/\/doi.org\/10.2340\/00015555-3718 (2021).","journal-title":"Acta Derm. Venereol."},{"key":"9490_CR6","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1097\/DSS.0000000000001566","volume":"44","author":"A Nazemi","year":"2018","unstructured":"Nazemi, A. et al. Eccrine porocarcinoma: New insights and a systematic review of the literature. Dermatol. Surg. 44, 1247\u20131261. https:\/\/doi.org\/10.1097\/DSS.0000000000001566 (2018).","journal-title":"Dermatol. Surg."},{"key":"9490_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1365-2133.2004.05815.x","volume":"150","author":"M Ameen","year":"2004","unstructured":"Ameen, M., Kwan, J. & Mortimer, P. S. Metastatic eccrine porocarcinoma presenting with lymphoedema. Br. J. Dermatol. 150, 607\u2013609. https:\/\/doi.org\/10.1046\/j.1365-2133.2004.05815.x (2004).","journal-title":"Br. J. Dermatol."},{"key":"9490_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1529-8019.2008.00243.x","volume":"21","author":"CW Brown Jr","year":"2008","unstructured":"Brown, C. W. Jr. & Dy, L. C. Eccrine porocarcinoma. Dermatol. Ther. 21, 433\u2013438. https:\/\/doi.org\/10.1111\/j.1529-8019.2008.00243.x (2008).","journal-title":"Dermatol. Ther."},{"key":"9490_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1365-2133.1982.tb00527.x","volume":"107","author":"M Shaw","year":"1982","unstructured":"Shaw, M., McKee, P. H., Lowe, D. & Black, M. M. Malignant eccrine poroma: A study of twenty-seven cases. Br. J. Dermatol. 107, 675\u2013680. https:\/\/doi.org\/10.1111\/j.1365-2133.1982.tb00527.x (1982).","journal-title":"Br. J. Dermatol."},{"key":"9490_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archderm.1963.01590230105015","volume":"88","author":"H Pinkus","year":"1963","unstructured":"Pinkus, H. & Mehregan, A. H. Epidermotropic eccrine carcinoma. A case combining features of eccrine poroma and Paget\u2019s dermatosis. Arch Dermatol. 88, 597\u2013606. https:\/\/doi.org\/10.1001\/archderm.1963.01590230105015 (1963).","journal-title":"Arch Dermatol."},{"key":"9490_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4103\/2229-5178.153018","volume":"6","author":"CA Maguire","year":"2015","unstructured":"Maguire, C. A., Kazlouskaya, V., Buchen, D., Heller, P. & Elston, D. M. Porocarcinoma with perineural invasion. Indian Dermatol. Online J. 6, 122\u2013125. https:\/\/doi.org\/10.4103\/2229-5178.153018 (2015).","journal-title":"Indian Dermatol. Online J."},{"key":"9490_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2340\/00015555-3000","volume":"98","author":"PKC Goon","year":"2018","unstructured":"Goon, P. K. C. et al. Eccrine porocarcinoma of the skin is rising in incidence in the east of England. Acta Derm. Venereol. 98, 991\u2013992. https:\/\/doi.org\/10.2340\/00015555-3000 (2018).","journal-title":"Acta Derm. Venereol."},{"key":"9490_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.amsu.2017.06.027","volume":"20","author":"AM Salih","year":"2017","unstructured":"Salih, A. M. et al. Porocarcinoma; presentation and management, a meta-analysis of 453 cases. Ann. Med. Surg. 20, 74\u201379. https:\/\/doi.org\/10.1016\/j.amsu.2017.06.027 (2017).","journal-title":"Ann. Med. Surg."},{"key":"9490_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7819-9-32","volume":"9","author":"U Marone","year":"2011","unstructured":"Marone, U. et al. Metastatic eccrine porocarcinoma: Report of a case and review of the literature. World J. Surg. Oncol. 9, 32. https:\/\/doi.org\/10.1186\/1477-7819-9-32 (2011).","journal-title":"World J. Surg. Oncol."},{"key":"9490_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321\u2013330. https:\/\/doi.org\/10.1038\/nature21349 (2017).","journal-title":"Nature"},{"key":"9490_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12022-019-09601-5","volume":"31","author":"C Ricci","year":"2020","unstructured":"Ricci, C. et al. Prognostic impact of MCPyV and TIL subtyping in merkel cell carcinoma: Evidence from a large European cohort of 95 patients. Endocr. Pathol. 31, 21\u201332. https:\/\/doi.org\/10.1007\/s12022-019-09601-5 (2020).","journal-title":"Endocr. Pathol."},{"key":"9490_CR17","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1158\/1078-0432.Ccr-11-3020","volume":"18","author":"H Sihto","year":"2012","unstructured":"Sihto, H. et al. Tumour infiltrating immune cells and outcome of merkel cell carcinoma: A population-based study. Clin. Cancer Res. 18, 2872\u20132881. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-11-3020 (2012).","journal-title":"Clin. Cancer Res."},{"key":"9490_CR18","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/cncr.21283","volume":"104","author":"F Piras","year":"2005","unstructured":"Piras, F. et al. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer 104, 1246\u20131254. https:\/\/doi.org\/10.1002\/cncr.21283 (2005).","journal-title":"Cancer"},{"key":"9490_CR19","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480\u2013489. https:\/\/doi.org\/10.1038\/nature10673 (2011).","journal-title":"Nature"},{"key":"9490_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Sautes-Fridman","year":"2019","unstructured":"Sautes-Fridman, C., Petitprez, F., Calderaro, J. & Fridman, W. H. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat. Rev. Cancer 19, 307\u2013325. https:\/\/doi.org\/10.1038\/s41568-019-0144-6 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"9490_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","volume":"74","author":"J Goc","year":"2014","unstructured":"Goc, J. et al. Dendritic cells in tumour-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res. 74, 705\u2013715. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1342 (2014).","journal-title":"Cancer Res."},{"key":"9490_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3892\/ijo.2020.5042","volume":"57","author":"Y Yamakoshi","year":"2020","unstructured":"Yamakoshi, Y. et al. Immunological potential of tertiary lymphoid structures surrounding the primary tumour in gastric cancer. Int. J. Oncol. 57, 171\u2013182. https:\/\/doi.org\/10.3892\/ijo.2020.5042 (2020).","journal-title":"Int. J. Oncol."},{"key":"9490_CR23","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3892\/ol.2020.11828","volume":"20","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. CD8(+) T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer. Oncol. Lett. 20, 2655\u20132664. https:\/\/doi.org\/10.3892\/ol.2020.11828 (2020).","journal-title":"Oncol. Lett."},{"key":"9490_CR24","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/bjc.2015.145","volume":"112","author":"N Hiraoka","year":"2015","unstructured":"Hiraoka, N. et al. Intratumoural tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer. Br. J. Cancer 112, 1782\u20131790. https:\/\/doi.org\/10.1038\/bjc.2015.145 (2015).","journal-title":"Br. J. Cancer"},{"key":"9490_CR25","first-page":"7610","volume":"7","author":"DS Behr","year":"2014","unstructured":"Behr, D. S. et al. Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas. Int. J. Clin. Exp. Pathol. 7, 7610\u20137621 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"9490_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/srep00765","volume":"2","author":"JL Messina","year":"2012","unstructured":"Messina, J. L. et al. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?. Sci. Rep. 2, 765. https:\/\/doi.org\/10.1038\/srep00765 (2012).","journal-title":"Sci. Rep."},{"key":"9490_CR27","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr2615","volume":"12","author":"VJ Tuominen","year":"2010","unstructured":"Tuominen, V. J., Ruotoistenmaki, S., Viitanen, A., Jumppanen, M. & Isola, J. ImmunoRatio: A publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res. 12, R56. https:\/\/doi.org\/10.1186\/bcr2615 (2010).","journal-title":"Breast Cancer Res."},{"key":"9490_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06680-x","author":"A Popp","year":"2020","unstructured":"Popp, A. et al. A New Intraepithelial gammadelta T-lymphocyte marker for celiac disease classification in formalin-fixed paraffin-embedded (FFPE) duodenal biopsies. Dig. Dis. Sci. https:\/\/doi.org\/10.1007\/s10620-020-06680-x (2020).","journal-title":"Dig. Dis. Sci."},{"key":"9490_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","volume":"144","author":"DE Elder","year":"2020","unstructured":"Elder, D. E., Bastian, B. C., Cree, I. A., Massi, D. & Scolyer, R. A. The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: Detailed analysis of 9 distinct subtypes defined by their evolutionary pathway. Arch. Pathol. Lab. Med. 144, 500\u2013522. https:\/\/doi.org\/10.5858\/arpa.2019-0561-RA (2020).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"9490_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1126\/science.1127515","volume":"313","author":"MT Landi","year":"2006","unstructured":"Landi, M. T. et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313, 521\u2013522. https:\/\/doi.org\/10.1126\/science.1127515 (2006).","journal-title":"Science"},{"key":"9490_CR31","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3389\/fimmu.2020.02105","volume":"11","author":"F Maibach","year":"2020","unstructured":"Maibach, F., Sadozai, H., Seyed Jafari, S. M., Hunger, R. E. & Schenk, M. Tumour-infiltrating lymphocytes and their prognostic value in cutaneous melanoma. Front. Immunol. 11, 2105. https:\/\/doi.org\/10.3389\/fimmu.2020.02105 (2020).","journal-title":"Front. Immunol."},{"key":"9490_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pathol.2017.10.011","volume":"50","author":"M Bosic","year":"2018","unstructured":"Bosic, M. et al. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas. Pathology 50, 327\u2013332. https:\/\/doi.org\/10.1016\/j.pathol.2017.10.011 (2018).","journal-title":"Pathology"},{"key":"9490_CR33","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1172\/JCI126185","volume":"129","author":"S Sekine","year":"2019","unstructured":"Sekine, S. et al. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. J. Clin. Invest. 129, 3827\u20133832. https:\/\/doi.org\/10.1172\/JCI126185 (2019).","journal-title":"J. Clin. Invest."},{"key":"9490_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1257452","volume":"6","author":"L Buisseret","year":"2017","unstructured":"Buisseret, L. et al. Tumour-infiltrating lymphocyte composition, organization and PD-1\/ PD-L1 expression are linked in breast cancer. Oncoimmunology 6, e1257452. https:\/\/doi.org\/10.1080\/2162402X.2016.1257452 (2017).","journal-title":"Oncoimmunology"},{"key":"9490_CR35","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1158\/1078-0432.CCR-13-2590","volume":"20","author":"G Di Caro","year":"2014","unstructured":"Di Caro, G. et al. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin. Cancer Res. 20, 2147\u20132158. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2590 (2014).","journal-title":"Clin. Cancer Res."},{"key":"9490_CR36","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1158\/1078-0432.CCR-14-2926","volume":"21","author":"NA Giraldo","year":"2015","unstructured":"Giraldo, N. A. et al. Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer. Clin. Cancer Res. 21, 3031\u20133040. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2926 (2015).","journal-title":"Clin. Cancer Res."},{"key":"9490_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fmed.2018.00232","volume":"5","author":"PA Vieyra-Garcia","year":"2018","unstructured":"Vieyra-Garcia, P. A. & Wolf, P. From early immunomodulatory triggers to immunosuppressive outcome: therapeutic implications of the complex interplay between the wavebands of sunlight and the skin. Front. Med. 5, 232. https:\/\/doi.org\/10.3389\/fmed.2018.00232 (2018).","journal-title":"Front. Med."},{"key":"9490_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00839.x","volume":"114","author":"P Wolf","year":"2000","unstructured":"Wolf, P. et al. Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumour necrosis factor-alpha. J. Invest. Dermatol. 114, 149\u2013156. https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00839.x (2000).","journal-title":"J. Invest. Dermatol."},{"key":"9490_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.taap.2003.08.019","volume":"195","author":"Y Matsumura","year":"2004","unstructured":"Matsumura, Y. & Ananthaswamy, H. N. Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol. 195, 298\u2013308. https:\/\/doi.org\/10.1016\/j.taap.2003.08.019 (2004).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"9490_CR40","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.4049\/jimmunol.0903719","volume":"184","author":"TP Singh","year":"2010","unstructured":"Singh, T. P. et al. 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23\/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J. Immunol. 184, 7257\u20137267. https:\/\/doi.org\/10.4049\/jimmunol.0903719 (2010).","journal-title":"J. Immunol."},{"key":"9490_CR41","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3389\/fimmu.2020.01266","volume":"11","author":"J Xiang","year":"2020","unstructured":"Xiang, J., Qiu, M. & Zhang, H. Role of dendritic epidermal T cells in cutaneous carcinoma. Front. Immunol. 11, 1266. https:\/\/doi.org\/10.3389\/fimmu.2020.01266 (2020).","journal-title":"Front. Immunol."},{"issue":"1","key":"9490_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/(SICI)1097-0215(19970106)70:1<98::AID-IJC15>3.0.CO;2-9","volume":"70","author":"LL Cavanagh","year":"1997","unstructured":"Cavanagh, L. L., Beroan, R., Basten, A. & Halliday, G. M. Dendritic epidermal T-cell involvement in induction of CD8+ T cell-mediated immunity against an ultraviolet radiation-induced skin tumour. Int. J. Cancer. 70(1), 98\u2013105 (1997).","journal-title":"Int. J. Cancer."},{"key":"9490_CR43","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1158\/0008-5472.CAN-15-1877","volume":"75","author":"SQ Wong","year":"2015","unstructured":"Wong, S. Q. et al. UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas. Cancer Res. 75, 5228\u20135234. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1877 (2015).","journal-title":"Cancer Res."},{"key":"9490_CR44","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.10.010","author":"M Kawazu","year":"2021","unstructured":"Kawazu, M. et al. HLA class I analysis provides insight into the genetic and epigenetic background of immune evasion in colorectal cancer with high microsatellite instability. Gastroenterology https:\/\/doi.org\/10.1053\/j.gastro.2021.10.010 (2021).","journal-title":"Gastroenterology"},{"key":"9490_CR45","doi-asserted-by":"publisher","unstructured":"McGranahan, N. et al. Allele-specific HLA loss and immune escape in lung cancer evolution. Cell 171, 1259\u20131271 e1211. https:\/\/doi.org\/10.1016\/j.cell.2017.10.001 (2017).","DOI":"10.1016\/j.cell.2017.10.001"},{"key":"9490_CR46","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-17-1327","volume":"8","author":"CS Grasso","year":"2018","unstructured":"Grasso, C. S. et al. Genetic mechanisms of immune evasion in colorectal cancer. Cancer Discov. 8, 730\u2013749. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1327 (2018).","journal-title":"Cancer Discov."},{"key":"9490_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger, S., Bao, R. & Gajewski, T. F. Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity. Nature 523, 231\u2013235. https:\/\/doi.org\/10.1038\/nature14404 (2015).","journal-title":"Nature"},{"key":"9490_CR48","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1158\/1078-0432.CCR-19-2027","volume":"26","author":"K Isomoto","year":"2020","unstructured":"Isomoto, K. et al. Impact of EGFR-TKI treatment on the tumour immune microenvironment in EGFR mutation-positive non-small cell lung cancer. Clin. Cancer Res. 26, 2037\u20132046. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2027 (2020).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09490-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09490-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09490-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:07:27Z","timestamp":1669338447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09490-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9490"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09490-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"17 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5529"}}